Search details
1.
Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.
Breast Cancer Res Treat
; 194(2): 279-295, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35666367
2.
Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.
Ann Surg Oncol
; 28(2): 975-984, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32794031
3.
High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
Int J Clin Oncol
; 25(12): 2025-2034, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32803488
4.
Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP.
Lab Invest
; 99(9): 1296-1308, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31024042
5.
External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
BMC Cancer
; 19(1): 978, 2019 Oct 22.
Article
in English
| MEDLINE | ID: mdl-31640622
6.
Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy.
World J Surg Oncol
; 16(1): 51, 2018 Mar 07.
Article
in English
| MEDLINE | ID: mdl-29514654
7.
ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.
Exp Mol Pathol
; 100(1): 145-50, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26687806
8.
Stromal-derived MAOB promotes prostate cancer growth and progression.
Sci Adv
; 10(6): eadi4935, 2024 Feb 09.
Article
in English
| MEDLINE | ID: mdl-38335292
9.
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer.
Cell Rep Med
; 5(2): 101388, 2024 Feb 20.
Article
in English
| MEDLINE | ID: mdl-38262412
10.
Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Pathol Res Pract
; 231: 153790, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35158121
11.
Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast.
J Clin Pathol
; 75(1): 18-23, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33214199
12.
Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer.
Oncogene
; 41(37): 4307-4317, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35986103
13.
MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.
Oncogene
; 40(7): 1362-1374, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33420365
14.
WLS-Wnt signaling promotes neuroendocrine prostate cancer.
iScience
; 24(1): 101970, 2021 Jan 22.
Article
in English
| MEDLINE | ID: mdl-33437943
15.
Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer.
Cancer Res
; 81(16): 4275-4289, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-34167949
16.
MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
Oncogene
; 39(16): 3305-3321, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32066880
17.
The differences of clinicopathologic characteristics among subgroups of reclassified HER2 fluorescence in situ hybridization (FISH) according to the ASCO/CAP 2018 breast cancer HER2 testing guidelines.
J Clin Pathol
; 73(5): 283-290, 2020 May.
Article
in English
| MEDLINE | ID: mdl-31732618
18.
Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study.
JMIR Med Inform
; 8(11): e19069, 2020 Nov 09.
Article
in English
| MEDLINE | ID: mdl-33164899
19.
Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p.
J Breast Cancer
; 22(1): 52-66, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30941233
20.
FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis.
Oncol Lett
; 15(6): 8206-8214, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29805554